SCHEMBL6403944

SCHEMBL6403944

Cc1cccc(NCc2nnc(S)n2-c2ccccc2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.60
KMT2A Q03164 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
VCP P55072 1/20 0.49
MAPT P10636 7/20 0.47
CASP3 P42574 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
TSHR P16473 2/20 0.45
HPGD P15428 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HTT P42858 1/20 0.43
KDM4E B2RXH2 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6403533 0.85 ALDH1A1 (0.55) ALDH1A1KMT2ASMN1; SMN2VCPMAPT
SCHEMBL6405215 0.81 GAA (0.62) ALDH1A1KMT2ASMN1; SMN2VCPMAPT
SCHEMBL6410540 0.77 ALDH1A1 (0.53) ALDH1A1KMT2ANPC1RAB9AVCP
SCHEMBL6406630 0.77 GAA (0.62) ALDH1A1KMT2ASMN1; SMN2TSHRCYP1A2
SCHEMBL19469983 0.75 POLB (0.57) ALDH1A1KMT2ASMN1; SMN2VCPMAPT
SCHEMBL12768238 0.74 GFER (0.60) SMN1; SMN2NPC1RAB9AVCPMAPT
SCHEMBL6404748 0.73 GAA (0.60) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL6404661 0.73 KMT2A (0.51) ALDH1A1KMT2ASMN1; SMN2MAPTCYP1A2
SCHEMBL10012459 0.72 MAPK1 (0.54) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL6411070 0.71 L3MBTL1 (0.62) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT ALDH1A1 720/4885KMT2A 2263/4885SMN1; SMN2 4793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.